Idexx Laboratories (IDXX) Other financing activities (2009 - 2026)

Idexx Laboratories has reported Other financing activities for 18 years, with the latest figure at $32.9 million in Q2 2026.

• On a quarterly basis, Other financing activities rose 89.92% year-over-year to $32.9 million in Q2 2026; TTM through Jun 2026 was $119.9 million, a 180.34% increase from a year earlier, with the FY2025 full-year figure at $93.4 million, up 109.84% from the prior year.
• Other financing activities was $32.9 million for Q2 2026 at Idexx Laboratories, up from $18.2 million in the prior quarter.
• The five-year high for Other financing activities was $51.0 million in Q3 2025, with the low at $4.9 million in Q3 2022.
• Average Other financing activities over 5 years is $15.1 million, with a median of $12.6 million recorded in 2022.
• The largest YoY upside for Other financing activities was 920.22% in 2025 against a maximum downside of 65.55% in 2025.
• Over 5 years, Other financing activities stood at $12.5 million in 2022, then decreased by 9.29% to $11.3 million in 2023, then rose by 16.99% to $13.3 million in 2024, then soared by 34.81% to $17.9 million in 2025, then soared by 84.19% to $32.9 million in 2026.
• The last three Other financing activities figures came in at $32.9 million (Q2 2026), $18.2 million (Q1 2026), and $17.9 million (Q4 2025), per Business Quant data.